collect the videos you love
collect | share | explore
Tag results for approval
sort by: relevance | recent
Results from all user's collections (105 out of ~105)
after downgrade boehner mcconnell and gop approval ratings plunge

a new cnn poll released today found that voters are angry and they are taking out their anger on john boehner mitch mcconnell and the entire republican party
us-obama approval: 46 approve 52 disapprove ap-gfk 1013-17

ap-gfk1013-1711 1000 adults 4 margin of errormode: live telephone interviewsap release national
us-obama approval: 39 approve 53 disapprove yougov 101-4

yougov economist101-411 1000 adults 37 margin of errormode: internetyougov release national
us-obama approval: 39 approve 53 disapprove yougov 108-11

yougov economist108-1111 1000 adults 39 margin of errormode: internetyougov release national
oh-kasich approval: 36 approve 52 disapprove quinnipiac 1017-23

quinnipiac 1017-2311 1668 registered voters 24 margin of errormode: live telephone interviewsquinnipiac release ohio
us-obama approval: 46 approve 52 disapprove cnn 1111-13

cnn orc1111-1311 1036 adults 3 margin of errormode: live telephone interviewscnn release national
us-obama approval: 42 approve 49 disapprove yougov 1022-25

yougov economist1022-2511 1000 adults 38 margin of errormode: internetyougov release national
nj-obama approval: 49 approve 44 disapprove monmouth 105-9

monmouth universtiy105-911 817 adults 34 margin of errormode: live telephone interviewsmonmouth release new jersey
meet the engineers

boston scientific nyse: bsx has received us food and drug administration fda approval for the synergy bioabsorbable polymer drug-eluting stent system bp-des for the treatment of coronary artery diseasewith this fda approval boston scientific will commence commercialization of the first and only bp-des in the us notably both the drug coating and the polymer which modulates drug release are fully absorbed shortly after drug elution is complete at three monthsthe synergy stent provides synchronized drug and polymer absorption it is designed to enable more rapid and complete arterial healing and to thereby reduce the risk of complications associated with long-term polymer exposure compared to currently-used drug-eluting stents des with permanent polymersto view the multimedia release go to:http:wwwmultivucomplayersenglish7223456-boston-scientific-fda-approval-synergy
us-obama approval: 44 approve 44 disapprove cbs 928-102

cbs news928-10111 1012 adults 3 margin of errormode: live telephone interviewscbs news toplines millionaire taxes story afghanistan story direction of the country release congress release national
conformity

a response to variablast039s science study tag:http:wwwyoutubecomwatchv=6fanyianvdchad to include more than one study sorry variablast couldn039t help myselfsherif m 1935 a study of some social factors in perception archives of psychology 27187 pp17-22asch se 1951 effects of group pressure upon the modification and distortion of judgment in h guetzkow ed groups leadership and men pittsburgh pa: carnegie pressasch se 1955 opinions and social pressure scientific american 1935 pp31-35berns gs chappelow j zink cf pagnoni g martin-skurski me and richards j 2005 039neurobiological correlates of social conformity and independence during mental rotation039 biological psychiatry 583 pp245-253weaver k garcia sm schwarz n ampamp miller dt 2007 inferring the popularity of an opinion from its familiarity: a repetitive voice can sound like a chorus journal of personality and social psychology 925 821-833
us-obama approval: 48 obama d 44 romney r time 109-10

time magazine109-1011 1001 adults838 likely votersmode: live telephone interviewstime release national
us-obama approval: 40 approve 53 disapprove democracy corps 1015-18

democracy corps d center for american progress1015-1811 1000 likely votersmode: live telephone interviewsdemocracy corps release national
cystinosis video

raptor pharmaceutical corp quotraptorquot or the quotcompanyquot nasdaq: rptp today announced that the us food and drug administration fda has approved procysbi cysteamine bitartrate delayed release capsules for the treatment of nephropathic cystinosis in adults and children 6 years and older in a phase 3 study procysbi showed consistent cystine depletion over the full 12-hour dosing period sustained levels of cysteamine have not historically been achieved in the majority of patients in this population studies have shown that sustained cystine depletion in patients may significantly delay disease progression including kidney dysfunction dialysis kidney transplant organ failure and premature deathto view multimedia news release go to http:wwwmultivucommnr61338-raptor-pharmaceutical-procysbi-fda-approval-nephropathic-cystinosis
the new aspiresr for vns therapy

following fda approval of the aspiresr generator for the vns therapy system in june 2015 more than a thousand patients with drug-resistant epilepsy across the united states have received this new treatment option many of these patients are experiencing benefits which have positively impacted their lives and are sharing their stories during epilepsy awareness month with the hope of encouraging others to seek new treatments for drug-resistant epilepsy numerous hospitals nationwide have begun providing the aspiresr device to patients with drug-resistant epilepsy a condition that affects as many as one-third of people with epilepsy causing them to have seizures in spite of treatment with antiepileptic medicationsthe vns therapy system is a minimally invasive option in which a medical device is placed under the skin in the upper chest area during an outpatient procedure the device sends mild electrical pulses through the vagus nerve to areas of the brain known to be associated with seizures the new aspiresr generator takes the vns therapy technology a step further detecting relative heart-rate increases that are often associated with seizures in people with epilepsy and providing responsive stimulation in an attempt to stop and shorten seizures and improve recoveryto view the multimedia release go to:http:wwwmultivucomplayersenglish7651751-livanova-aspiresr-treatment